Severely impaired insulin signaling in chronic wounds of diabetic ob/ob mice: A potential role of tumor necrosis factor-α

American Journal of Pathology

Volumn 168, Issue 3, 2006, Pages 765-777

  Goren, Itamar ^a   Müller, Elke ^a   Pfeilschifter, Josef ^a   Frank, Stefan ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE; GLYCOGEN SYNTHASE KINASE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; LEPTIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY V1Q; PROTEIN TYROSINE PHOSPHATASE 1B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC WOUND; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME PHOSPHORYLATION; EPITHELIZATION; FEMALE; INFLAMMATION; INSULIN RESISTANCE; KERATINOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TISSUE REGENERATION; WOUND HEALING IMPAIRMENT;

EID: 33644651282     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.050293     Document Type: Article

References (36)

1. Pryce TD: A case of perforating ulcers of both feet associated with diabetes and ataxic symptoms. Lancet 1887, 2:11-12
2. Boulton AJM: The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia 2004, 47:1343-1353
3. Reiber GE, Ledoux WR: Epidemiology of diabetic foot ulcers and amputations: evidence for prevention. The Evidence Base for Diabetes Care. Edited by R Williams, W Herman, AL Kinmonth, NJ Wareham. Chichester, UK, Wiley, 2002, pp 641-665
4. Carrington AL, Abbott CA, Griffiths J, Jackson N, van Ross ERE, Boulton AJM: A foot care program for diabetic unilateral amputees. Diabetes Care 2001, 24:216-221
5. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, Hann AW, Hussein A, Jackson N, Johnson KE, Ryder CH, Torkington R, Van Ross ER, Whalley AM, Widdows P, Williamson S, Boulton AJ: The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabetic Med 2002, 20:377-384
6. Muller IS, de Grauw WJ, van Gerwen WH, Bartelink ML, van Den Hoogen HJ, Rutten GE: Foot ulceration and lower limb amputation in type 2 diabetic patients in Dutch primary health care. Diabetes Care 2002, 25:570-574
7. Jeffcoate WJ, Harding KG: Diabetic foot ulcers. Lancet 2003, 361:1545-1551
8. Reiber GE, Lipsky BA, Gibbons GW: The burden of diabetic foot ulcers. Am J Surg 1998, 176:53-103
9. Apelqvist J, Larsson J, Agardh CD: Long-term prognosis for diabetic patients with foot ulcers. J Intern Med 1993, 233:485-491
10. Faglia E, Favales F, Morabito A: New ulceration, new major amputation, and survival rats in diabetic subjects hospitalized for foot ulceration from 1990 to 1993: a 6.5 year follow-up. Diabetes Care 2001, 24:78-83
11. Wieman TJ, Smiell JM, Su Y: Efficacy and safety of topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers: a phase III randomized placebo-controlled double-blind study. Diabetes Care 1998, 21:822-827
12. Coleman DL: Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 1978, 14:141-148
13. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432
14. Frank S, Stallmeyer B, Kämpfer H, Kolb N, Pfeilschifter J: Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair. J Clin Invest 2000, 106:501-509
15. Goren I, Kämpfer H, Podda M, Pfeilschifter J, Frank S: Leptin and wound inflammation in diabetic ob/ob mice: differential regulation of neutrophil and macrophage influx and a potential role for the scab as a sink for inflammatory cells and mediators. Diabetes 2003, 52:2821-2832
16. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995, 269:540-543
17. Wertheimer E, Spravchikov N, Trebicz M, Gartsbein M, Accili D, Avinoah I, Nofeh-Moses S, Sizyakov G, Tennenbaum T: The regulation of skin proliferation and differentiation in the IR null mouse: implications for skin complications of diabetes. Endocrinology 2001, 142:1234-1241
18. Spravchikov N, Sizyakov G, Gartsbein M, Accili D, Tennenbaum T, Wertheimer E: Glucose effects on skin keratinocytes: implications for diabetes skin complications. Diabetes 2001, 50:1627-1635
19. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91
20. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB: The expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995, 95:2111-2119
21. Mantzoros CS, Mosohos S, Avramopoulos I, Kaklamani V, Liolios A, Doulgerakis DE, Griveas I, Katsilambros N, Flier JS: Leptin concentrations in relation to body mass index and the tumor necrosis factor-α system in humans. J Clin Endocrinol Metab 1997, 82:3408-3413
22. Schmidt Ml, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP, Heiss G: Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities Study): a cohort study. Lancet 1999, 353:1649-1652
23. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM: C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001, 286:327-334
24. Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, Tracy RP: The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 2001, 50:2384-2389
25. Echtenacher B, Falk W, Mannel DN, Krammer PH: Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J Immunol 1990, 145:3762-3766
26. Stallmeyer B, Kämpfer H, Kolb N, Pfeilschifter J, Frank S: the function of nitric oxide in wound repair: inhibition of inducible nitric oxide-synthase severely impairs wound reepithelialization. J Invest Dermatol 1999, 113:1090-1098
27. Frank S, Stallmeyer B, Kämpfern, Kolb N, Pfeilschifter J: Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair. FASEB J 1999, 13:2002-2014
28. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159
29. Kämpfer H, Kalina U, Mühl H, Pfeilsohifter J, Frank S: Counterregulation of interleukin-18 mRNA and protein expression during cutaneous wound repair in mice. J Invest Dermatol 1999, 113:369-374
30. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63
31. Ring BD, Scully S, Corrine CR, Baker MB, Cullen MJ, Pelleymounter MA, Danilenko DM: Systemically and topically administered leptin both accelerate wound healing in diabetic ob/ob mice. Endocrinology 2000, 141:446-449
32. Johnson TO, Ermolieff J, Jirousek MR: Protein tyrosine phosphatase 1B inhibitors for diabetes. Nat Rev Drug Discov 2002, 1:696-709
33. Tao J, Malbon CC, Wang HY: Insulin stimulates tyrosine phosphorylation and inactivation of protein-tyrosine phosphatase 1B in vivo. J Biol Chem 2001, 276:29520-29525
34. Doble BW, Woodgett JR: GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 2003, 116:1175-1186
35. Zimmet P, Albert KGMM, Shaw J: Global and societal implications of the diabetes epidemic. Nature 2001, 414:782-787
36. Wetzler C, Kämpfer H, Stallmeyer B, Pfeilschifter J, Frank S: Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 2000, 115:245-252